CN109045043A - It is a kind of to treat antiherpetic - Google Patents
It is a kind of to treat antiherpetic Download PDFInfo
- Publication number
- CN109045043A CN109045043A CN201810800010.1A CN201810800010A CN109045043A CN 109045043 A CN109045043 A CN 109045043A CN 201810800010 A CN201810800010 A CN 201810800010A CN 109045043 A CN109045043 A CN 109045043A
- Authority
- CN
- China
- Prior art keywords
- parts
- pain
- treatment
- bleb
- antiherpetic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Abstract
Antiherpetic is treated the present invention provides a kind of, raw material includes: 10-20 parts of Ofloxacin, 12-21 parts of tobramycin dexamethasone, 13-18 parts of acyclovir by weight.Medicine of the invention is put on affected part, fast pain relief is can reach, treats sick and wounded effect, the treatment suitable for a variety of blebs, epifolliculitis, eczema etc..
Description
Technical field
The invention belongs to pharmaceutical technology fields, and in particular to a kind of to treat antiherpetic.
Background technique
The problems such as because of people's daily life now, work and rest rule, the problem for causing sleep insufficiency, operating pressure big etc. are made
It the problems such as at resistance decline, endocrine disturbance, stomach endocrine disturbance, indigestion, irritable bowel syndrome, causes more
Kind bleb, epifolliculitis, eczema, the illness rate of disease dramatically increase.The present invention is according to conventional formulation, in conjunction with clinical practice situation,
It obtains the illnesss such as treatment bleb, epifolliculitis, eczema, can more quickly and effectively cure patient's slight illness.
Summary of the invention
Antiherpetic is treated the purpose of the present invention is to provide a kind of, is had to the disease such as bleb, epifolliculitis, eczema significant special
Effect.
To achieve the above object, the present invention adopts the following technical scheme:
A kind of to treat antiherpetic, raw materials used include: 10-20 parts of Ofloxacin, tobramycin dexamethasone by weight
12-21 parts, 13-18 parts of acyclovir.
Preferably, raw materials used includes: 15 parts of Ofloxacin, 15 parts of tobramycin dexamethasone, Ah former times by weight
16 parts of Lip river Wei.
The application method of the externally applied drug of the treatment bleb, epifolliculitis, eczema pain: by Ofloxacin, tobramycin
Sai meter Song, acyclovir are put on affected part after proportioning.
There is the anti-inflammatory of clearing damp rash to kill for the special efficacy externally applied drug of the pain such as treatment bleb, epifolliculitis, eczema prepared by the present invention
Bacterium analgesic, dampness elimination and other effects, are put at the sufferers such as bleb, epifolliculitis, eczema, and it is sick and wounded to can reach fast pain relief, treatment
Effect, the treatment suitable for bleb, epifolliculitis, eczematosis.It can be relieved pain at once after spreading this medicine in fierce pain, 2 is small
When after pain almost disappear.
Specific embodiment
In order to make content of the present invention easily facilitate understanding, With reference to embodiment to of the present invention
Technical solution is described further, but the present invention is not limited only to this.
Embodiment 1
By Ofloxacin 15mg, tobramycin dexamethasone 15mg, acyclovir 16mg allotment to get treatment bleb, epifolliculitis,
The special efficacy externally applied drug of eczema pain.
Embodiment 2
By Ofloxacin 10mg, tobramycin dexamethasone 12mg, acyclovir 13mg allotment to get treatment bleb, epifolliculitis,
The special efficacy externally applied drug of eczema pain.
Embodiment 3
By Ofloxacin 20mg, tobramycin dexamethasone 21mg, acyclovir 18mg allotment to get treatment bleb, epifolliculitis,
The special efficacy externally applied drug of eczema pain.
The application method of the special efficacy externally applied drug of above-mentioned treatment herpes zoster pain: by Ofloxacin, tobramycin dexamethasone, Ah
VACV is put on affected part after deploying in proportion, smearing drug is primary within 30 minutes, medication in one day 5 ~ 6 times.7 days courses for the treatment of.
Typical case
Case 1: Chen, male 37 years old, suffer from bleb for many years, after smearing one course for the treatment of of externally applied drug prepared with embodiment 1, pain is obvious
Improvement bleb disappears.
Case 2: Mr. Wang, male 35 years old, suffer from bleb hospitalization two weeks and not improving, and smear the external application prepared with embodiment 1
2 hours pain of medicine disappears, and after a course for the treatment of, symptom disappears, and genital area can move freely.
Case 3: Cai so-and-so, male 75 years old, suffers from shingles zoster repeatedly for many years, in great pain, smear prepared with embodiment 1 it is outer
After two courses for the treatment of of medication, symptom is obviously improved disappearance, can go into the street and play.
Case 4: it is blue so-and-so, female, 51 years old, patient back bleb smeared externally applied drug one prepared with embodiment 1 for many years repeatedly
It fully recovers after the course for the treatment of.
Case 5: Shi, female, 33 years old, after suffering from bleb eczema scorching many years, smearing one course for the treatment of of externally applied drug prepared with embodiment 1
Symptom is obviously improved, and does not occur pain symptom again more than 2 years after treating.
Case 6: Mr. Lin, female 53 years old, suffer from lip bleb repeatedly for many years, in great pain, smear with outside the preparation of embodiment 1
Medication is fully recovered after seven days has no pain again over the past half year.
Case 7: clock so-and-so, female 51 years old, suffers from epifolliculitis eczema and has seen many doctors not feel any better for many years repeatedly, smears with real
It fully recovers after applying one course for the treatment of of externally applied drug of the preparation of example 1.
Case 8: leaf, male 26 years old, suffer from head epifolliculitis finger eczema repeatedly for many years, smear the external application prepared with embodiment 1
Recovery from illness has no pain again for a long time after one course for the treatment of of medicine.
Case 9: tall building, male 45 years old, suffer from that lip neck lower part bleb is in great pain for many years, smear prepared with embodiment 1 it is outer
Pain is not shown in two treatment recoveries from illness of medication again
Case 10: Ruan, often interrogation everywhere in great pain is invalid for many years for a few place's blebs within 27 years old, smears with the external application for implementing 1 preparation
The mostly rear recovery from illness of one course for the treatment of of medicine has no pain again for a long time.
Long-term acyclovir, Ofloxacin or the tobramycin dexamethasone treatment bleb of being used alone does not play alleviation work
With, and disappeared substantially using pain in 2 hours after treatment antiherpetic of the invention, basic rehabilitation in one to two days.
The foregoing is merely presently preferred embodiments of the present invention, it is all according to equivalent change made by the present patent application patent atmosphere with
Modification, all should belong to covering scope of the invention.
Claims (2)
1. a kind of treat antiherpetic, it is characterised in that: its raw material includes: 10-20 parts of Ofloxacin, tobramycin by weight
12-21 parts of dexamethasone, 13-18 parts of acyclovir.
2. a kind of antiherpetic is treated according to claim 1, it is characterised in that: its raw material includes: oxygen fluorine by weight
15 parts of husky star, 15 parts of tobramycin dexamethasone, 16 parts of acyclovir.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810800010.1A CN109045043A (en) | 2018-07-20 | 2018-07-20 | It is a kind of to treat antiherpetic |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810800010.1A CN109045043A (en) | 2018-07-20 | 2018-07-20 | It is a kind of to treat antiherpetic |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN109045043A true CN109045043A (en) | 2018-12-21 |
Family
ID=64817612
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810800010.1A Pending CN109045043A (en) | 2018-07-20 | 2018-07-20 | It is a kind of to treat antiherpetic |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN109045043A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4035669A4 (en) * | 2019-09-30 | 2022-11-30 | Plantarx Limited | Preparation of drug for treating alzheimer's disease |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101947269A (en) * | 2010-09-03 | 2011-01-19 | 刘安庆 | Medicine for treating viral herpes |
| WO2012037445A2 (en) * | 2010-09-17 | 2012-03-22 | Drexel University | Novel applications for alliform carbon |
| CN106619735A (en) * | 2016-12-28 | 2017-05-10 | 河南水晶头文化传媒有限公司 | Medicine for treating acute herpetic stomatitis and preparing method thereof |
-
2018
- 2018-07-20 CN CN201810800010.1A patent/CN109045043A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101947269A (en) * | 2010-09-03 | 2011-01-19 | 刘安庆 | Medicine for treating viral herpes |
| WO2012037445A2 (en) * | 2010-09-17 | 2012-03-22 | Drexel University | Novel applications for alliform carbon |
| CN106619735A (en) * | 2016-12-28 | 2017-05-10 | 河南水晶头文化传媒有限公司 | Medicine for treating acute herpetic stomatitis and preparing method thereof |
Non-Patent Citations (3)
| Title |
|---|
| 王枫荻等: "妥布霉素地塞米松眼膏治疗儿童湿疹的临床疗效观察", 《中国中西医结合皮肤性病学杂志》 * |
| 靳培英，王怀劬，刘训荃，李惠珠: "氧氟沙星凝胶外用的临床疗效", 《临床皮肤科杂志》 * |
| 颜坚等: "妥布霉素地塞米松滴眼液联合阿昔洛韦滴眼液治疗单纯疱疹病毒性角膜炎的疗效观察", 《中国当代医药》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4035669A4 (en) * | 2019-09-30 | 2022-11-30 | Plantarx Limited | Preparation of drug for treating alzheimer's disease |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN109045043A (en) | It is a kind of to treat antiherpetic | |
| CN103393813B (en) | Pure Chinese herbal medicine preparation for treating burns and scalds as well as pyogenic infections and open traumas | |
| CN104587412A (en) | Mouth mucosa patch for treating tracheospasm | |
| CN101129425B (en) | Traditional Chinese medicine for treating zoster | |
| CN103251683B (en) | External medicine for treating herpes zoster | |
| CN113413423A (en) | Traditional Chinese medicine itching relieving oil | |
| CN102247580B (en) | A kind of medicated wine for the treatment of rheumatism, hyperosteogeny and old injury | |
| CN103989797B (en) | A kind of Chinese medicine preparation for the treatment of infant eczema | |
| CN1772111A (en) | Medicinal wine for treating rheumatism and rheumatoid disease and its prepn | |
| CN1059560C (en) | Medicinal herbs "Biketong" for curing numbness | |
| CN104958359A (en) | Compound traditional Chinese medicine preparation and application thereof in treatment of warts and cervical cancer | |
| CN109276594A (en) | A kind of Chinese medicine composition and preparation method thereof for treating herpes zoster | |
| CN107638468A (en) | It is a kind of to be used to treat Chinese medicine composition of rhinitis chronic and application thereof | |
| CN107715095A (en) | A kind of Chinese medicine preparation for treating paediatrics cough with lung heat | |
| CN106177686A (en) | A kind of Chinese medicine for treating urticaria | |
| CN106177852A (en) | One is used for treating beriberic Chinese medicine | |
| CN107375422A (en) | Treatment part catarrh symptom liniment and preparation method thereof | |
| CN106166287A (en) | A kind of Chinese medicine for treating skin pruritus | |
| CN101152512A (en) | Traditional Chinese medicine for treating allergic dermatitis | |
| CN106421422A (en) | Traditional Chinese medicine composition for curing insomnia | |
| CN101152314A (en) | Traditional Chinese medicine for treating baby napkin dermatitis | |
| CN1297294C (en) | Extemal remedy for treating eczema | |
| CN101279032A (en) | External use medicament for curing itch | |
| CN104547046A (en) | Traditional Chinese medicinal composition for treating nasosinusitis | |
| CN108671087A (en) | A kind of pharmaceutical composition and its preparation method and application for treating brandy nose |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181221 |